Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Marie-France Savard"'
Autor:
Sharon F. McGee, Mark Clemons, Gregory Pond, Jean-Michel Caudrelier, Michelle Liu, Mashari Jemaan Alzahrani, Terry L. Ng, Arif A. Awan, Sandeep Sehdev, John Hilton, Marie-France Savard, Lesley Fallowfield, Vikaash Kumar, Orit Freedman, Lisa Vandermeer, Brian Hutton, Jean-Marc Bourque
Publikováno v:
Current Oncology, Vol 31, Iss 8, Pp 4531-4545 (2024)
Concerns exist regarding increased toxicities, including endocrine therapy toxicity, with concurrent radiation and endocrine therapy in early breast cancer (EBC). We present a pragmatic, randomized trial comparing concurrent versus sequential endocri
Externí odkaz:
https://doaj.org/article/2fd4e23646ed407ea822b33ad3dcffab
Autor:
Sarah Cook, Shabbir Alibhai, Rajin Mehta, Marie-France Savard, Caroline Mariano, Dominique LeBlanc, Danielle Desautels, Rossanna Pezo, Xiaofu Zhu, Karen A. Gelmon, Tina Hsu
Publikováno v:
Current Oncology, Vol 31, Iss 7, Pp 3783-3797 (2024)
Most patients diagnosed with and dying from cancer in Canada are older adults, with aging contributing to the large projected growth in cancer incidence. Older adults with cancer have unique needs, and on a global scale increasing efforts have been m
Externí odkaz:
https://doaj.org/article/9ddc10268b754f80b752e768c4d7b22c
Autor:
Parvaneh Fallah, Lucas Clemons, Michelle Bradbury, Lisa Vandermeer, Mark Clemons, Julie Renaud, Marie-France Savard
Publikováno v:
Current Oncology, Vol 31, Iss 5, Pp 2488-2496 (2024)
Background: Unsolicited patient feedback (compliments and complaints) should allow the healthcare system to address and improve individual and overall patient, family, and staff experiences. We evaluated feedback at a tertiary cancer centre to identi
Externí odkaz:
https://doaj.org/article/cbc6c86056784ef48b81635ad34e9a50
Autor:
Ana-Alicia Beltran-Bless, Mark Clemons, Lisa Vandermeer, Khaled El Emam, Terry L. Ng, Sharon McGee, Arif Ali Awan, Gregory Pond, Julie Renaud, Gwen Barton, Brian Hutton, Marie-France Savard
Publikováno v:
Current Oncology, Vol 31, Iss 3, Pp 1376-1388 (2024)
Patients, families, healthcare providers and funders face multiple comparable treatment options without knowing which provides the best quality of care. As a step towards improving this, the REthinking Clinical Trials (REaCT) pragmatic trials program
Externí odkaz:
https://doaj.org/article/f3613d1f36524433a33a1ce65b55e6df
Autor:
Michelle Bradbury, Marie-France Savard, Lisa Vandermeer, Lucas Clemons, Gregory Pond, John Hilton, Mark Clemons, Sharon McGee
Publikováno v:
Current Oncology, Vol 30, Iss 12, Pp 10477-10487 (2023)
Despite evidence from clinical trials showing the efficacy of shorter durations of therapy, most HER2-positive early breast cancer (EBC) patients receive a year of anti-HER2 therapy. A survey of Canadian oncologists was conducted online, with electro
Externí odkaz:
https://doaj.org/article/eac73c25c12745ccae0f763fd8569f7a
Autor:
Emily B. Jackson, Lauren Curry, Caroline Mariano, Tina Hsu, Sarah Cook, Rossanna C. Pezo, Marie-France Savard, Danielle N. Desautels, Dominique Leblanc, Karen A. Gelmon
Publikováno v:
Current Oncology, Vol 31, Iss 1, Pp 145-167 (2023)
The prevalence of breast cancer amongst older adults in Canada is increasing. This patient population faces unique challenges in the management of breast cancer, as older adults often have distinct biological, psychosocial, and treatment-related cons
Externí odkaz:
https://doaj.org/article/1798a6555f8e4fa88494ee1508bf179a
Publikováno v:
Current Oncology, Vol 29, Iss 6, Pp 4125-4137 (2022)
The advent of HER2-targeted therapies has led to an important shift in the management of HER2-positive early breast cancer. However, initial treatment approaches apply uniform treatment regimens to all patients, with significant treatment-related and
Externí odkaz:
https://doaj.org/article/98a425f5899b4f86860b0b6ec8fb1232
Publikováno v:
Current Oncology, Vol 29, Iss 1, Pp 383-391 (2022)
Metastatic breast cancer (MBC) patient outcomes may vary according to distinct health care payers and different countries. We compared 291 Alberta (AB), Canada and 9429 US patients < 65 with de novo MBC diagnosed from 2010 through 2014. Data were ext
Externí odkaz:
https://doaj.org/article/bc447f1f6e7b46539927821180b6c8cb
Autor:
Marie-France Savard, Mashari Jemaan Alzahrani, Deanna Saunders, Lynn Chang, Angel Arnaout, Terry L. Ng, Muriel Brackstone, Lisa Vandermeer, Tina Hsu, Ari Ali Awan, Katherine Cole, Gail Larocque, Mark Clemons
Publikováno v:
Current Oncology, Vol 28, Iss 6, Pp 5215-5226 (2021)
Older patients with lower-risk hormone receptor-positive (HR+) breast cancer are frequently offered both radiotherapy (RT) and endocrine therapy (ET) after breast-conserving surgery (BCS). A survey was performed to assess older patients’ experience
Externí odkaz:
https://doaj.org/article/be0393d15e4040a2b885877b2e669db2
Management Strategies for Older Patients with Low-Risk Early-Stage Breast Cancer: A Physician Survey
Autor:
Mashari Alzahrani, Mark Clemons, Lynn Chang, Lisa Vendermeer, Angel Arnaout, Gail Larocque, Katherine Cole, Tina Hsu, Deanna Saunders, Marie-France Savard
Publikováno v:
Current Oncology, Vol 29, Iss 1, Pp 1-13 (2021)
When managing older patients with lower-risk hormone-receptor-positive (HR+), HER2 negative (HER2−) early-stage breast cancer (EBC), the harms and benefits of adjuvant therapies should be taken into consideration. A survey was conducted among Canad
Externí odkaz:
https://doaj.org/article/5af5145ba17a4a0baa6f785943263e70